RHONDA MCANALLY: Open Payments
NPI 1962174227 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$799 in 42 payments from 13 companies in 2025. Trend: 2023 $441 · 2024 $881 · 2025 $799
Food & beverage: $799
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $197 |
| AstraZeneca Pharmaceuticals LP | 11 | $196 |
| Novo Nordisk Inc | 8 | $154 |
| Lilly USA, LLC | 3 | $47 |
| Dexcom, Inc. | 2 | $46 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $17 |
Products named: CAPLYTA, Rybelsus, AIRSUPRA, BREZTRI, MOUNJARO, Dexcom G6 Transmitter, FARXIGA, Wegovy.
Industry payments across TN — which companies pay providers there.
